A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma
Open Access
- 4 December 1997
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (23), 1659-1665
- https://doi.org/10.1056/nejm199712043372304
Abstract
An inhaled glucocorticoid is currently the medication of choice for long-term control of persistent asthma in children. The role of long-acting β2-adrenergic–receptor agonists, such as salmeterol, needs to be defined.Keywords
This publication has 27 references indexed in Scilit:
- Inhaled steroids and the risk of hospitalization for asthmaPublished by American Medical Association (AMA) ,1997
- Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoidsActa Paediatrica, 1997
- Growth and the growth hormone axis in prepubertal children with asthmaThe Journal of Pediatrics, 1995
- Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroidsActa Paediatrica, 1994
- Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic childrenJournal of Allergy and Clinical Immunology, 1993
- Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- Growth retardation in children on steroids for asthmaThe Lancet, 1991
- GROWTH RETARDATION IN ASTHMATIC CHILDREN TREATED WITH INHALED BECLOMETHASONE DIPROPIONATEThe Lancet, 1988
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical and Experimental Allergy, 1977
- Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosolArchives of Disease in Childhood, 1974